Evidence map›Paper›PMID 40847537›Full record

ArticleProteins2026

Model Quality Assessment for CASP16.

Alisia Fadini, Gabriel Studer, Randy J Read

Abstract read
In one paragraph

Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alisia FadiniCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0001-5246-9124
Gabriel StuderBiozentrum, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-0462-1456
Randy J ReadCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0001-8273-0047

Funding

Prospective analysis to determine model accuracy performance and boundaries in the post-AlphaFold2 environmentR01GM100482 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIDELIS, KRZYSZTOF A · 2012 to 2025
$11.1M
Biotechnology and Biological Sciences Research Council BB/Y009398/1NIGMS NIH HHS R01 GM100482US National Institute of General Medical Sciences (NIGMS/NIH) R01GM100482Wellcome TrustWellcome Trust 209407/Z/17/Z
6 · The paper itself

Abstract

The CASP16 evaluation of model accuracy (EMA) experiment assessed the ability of predictors to estimate the accuracy of predicted models, with a particular emphasis on multimeric assemblies. Expanding on the CASP15 framework, CASP16 introduced a new evaluation mode (QMODE3) focused on selecting high-quality models from large-scale AlphaFold2-derived model pools generated by MassiveFold. Three primary evaluation tasks were therefore conducted: QMODE1 assessed global structure accuracy, QMODE2 focused on the accuracy of interface residues, and QMODE3 tested model selection performance. Predictors were evaluated using a diverse set of OpenStructure-based metrics, and a novel penalty-based ranking scheme was developed for QMODE3 to handle score interdependence and varying prediction quality distributions. Additionally, we explored the accuracy and utility of predicted local confidence measures now made available on a per-atom basis by methods that invoke AlphaFold3. Results showed that methods incorporating AlphaFold3-derived features-particularly per-atom pLDDT-performed best in estimating local accuracy and in utility for experimental structure solution. For QMODE3, performance varied significantly across monomeric, homomeric, and heteromeric target categories and underscored the ongoing challenge of evaluating complex assemblies.

Indexed as

Computational BiologyModels, MolecularProteinsSoftwareAlgorithmsDatabases, ProteinProtein ConformationProtein FoldingProtein MultimerizationProteinscomputational molecular biologymolecular modelsprotein conformationprotein domains

Identifiers

PMID40847537
PMCPMC12750031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.